- Trials with a EudraCT protocol (873)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (46)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: EFFECTS OF TREATMENT WITH ALBENDAZOLE ON GROWTH, ANEMIA AND PHYSICAL FITNESS IN KENYAN PRIMARY SCHOOL CHILDREN WITH HOOKWORM TRICHURIS AND ASCARIS INFECTIONS |
| Active substance: ALBENDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46323 |
| Study title: Kokil-S. Anemia in dermatitis seborrheica and the curative effect of biotin. Annales paediatrici. International review of pediatrics, {Ann-Paediatr}, Feb 1956, vol. 186, no. 2, p. 79-82, ISSN: 0365-4966.Kokil-S. Anemia in dermatitis seborrheica and the curative effect of biotin. Annales paediatrici. International review of pediatrics, {Ann-Paediatr}, Feb 1956, vol. 186, no. 2, p. 79-82, ISSN: 0365-4966. |
| Active substance: BIOTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22589 |
| Study title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) on Anemia and Quality of Life in Children With Cancer Undergoing Myelosuppressive Chemotherapy |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): PR99-11-034_Interventional_Epoetin alfa.xls |
| View full study record |
| Document reference: 26583 |
| Study title: Correcton of renal anemia with recombinant human erythropoietin (rhEPO) ameliorates growth in children with preterminal renal failure (PTRF) P-238 Müller-Weifel et. al.: [Abstract]. (In: 9th Congress of the International Pediatric Nephrology Association) Pediatr Nephrol 1992;6(5):C170 P-149 |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26579 |
| Study title: Correcton of renal anemia with recombinant human erythropoietin (rhEPO) ameliorates growth in children with preterminal renal failure (PTRF) P-238 Müller-Weifel et. al.: [Abstract]. (In: 9th Congress of the International Pediatric Nephrology Association) Pediatr Nephrol 1992;6(5):C170 |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): shannon1992_eprex.pdf |
| View full study record |
| Document reference: 26586 |
| Study title: Double-Blind, Placebo-Controlled, Study to Determine Safety and Efficacy of R-HuEPO in the Anemia of Prematurity |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26582 |
| Study title: Placebo-Controlled, Double-Blind, Dose-ranging Study of the Safety and Efficacy of recombinant human Erythropoietin (R-HUEPO) in the Prophylaxis and Treatment of the Anemia of Prematurity |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): CC 2574-P129_Interventional_Epoetin alfa.xls |
| View full study record |
| Document reference: 26581 |
| Study title: Recombinant human Erythropoietin (R-HUEPO) in the Anemia of Prematurity: A Multi-Center Double-Blind, Placebo-Controlled, Study |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26584 |
| Study title: Recombinant human Erythropoietin (R-HUEPO) in the Anemia of Prematurity: A Multi-Center Double-Blind, Placebo-Controlled, Study |
| Active substance: ERYTHROPOIETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26585 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL ANEMIA IN GRANULOCYTOPENIC PEDIATRIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27507 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL ANEMIA IN GRANULOCYTOPENIC PEDIATRIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27871 |
| Study title: Kojima, S., Hibi, S., Kosaka, Y., et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-Stimulating factor in children with acquired aplastic anemia Blood 96(6): 2049-2054.Kojima, S., Hibi, S., Kosaka, Y., et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-Stimulating factor in children with acquired aplastic anemia Blood 96(6): 2049-2054. |
| Active substance: FILGASTRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27278 |
| Study title: Godo A et al: Comparison of efficacy and tolerability netween iton protein succinylate and iron sulphate - Study in 80 patients with iron deficiency anemia. General Pediatric Service, University Hospital Center, Tirana, Albania. |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27208 |
| Study title: Mandich Z & Angebrandt S: Clinical trial - Iron protein succinylate (Legofer) in threatment of anemia. Pediatric Clinic, Clinical Hospital, Osijek, Croatia. |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27206 |
| Study title: Markova G: Hypochromic anemia in the breast-feeding age (Treatment with Legofer). Healt Care center Lisiche, Skopje, Macedonia |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27203 |
| Study title: Nakich M et al: Legofer in the treatment of sideropenic anemia in children with a solid tumor. Pediatrics Clinic Zagreb, Croatia |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27207 |
| Study title: Smokvina M: Trivalen iron-protein succinylat (Legofer) in treatment of sideropenic anemia in children. Hematologic - Onkologic clinical care unit, Pediatrics clinic, Rijeka, Croatia. |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27204 |
| Study title: Mamula, P. et al. Total Dose Intravenous Infusion of Iron Dextran for Iron-Deficiency Anemia in Children With Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition (2002) 34:286-290. |
| Active substance: FERRIC OXIDE DEXTRAN COMPLEX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27195 |
| Study title: Peck, S.N. et al. Safety and efficacy of iron dextran infusions in children with inflammatory bowel disease and iron deficiency anemia, Journal of Pediatric Gastroenterology and Nutrition (1998) 27: 487. |
| Active substance: FERRIC OXIDE DEXTRAN COMPLEX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27196 |
| Study title: Atanasova B et al: The results of application of recombinant eritropoetin for prevention of anemia (cases) of prematurely borne in department of neonatology in University Hospital Pleven. Department of Neonatology, University Hospital- Pleven & House of Medical and social care – Pleven, Bulgaria |
| Active substance: FERRIC PROTEINSUCCINYLATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27199 |
